SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-23-008651
Filing Date
2023-03-17
Accepted
2023-03-17 16:31:01
Documents
20

Document Format Files

Seq Description Document Type Size
1 PRE 14A evok-20230317.htm   iXBRL PRE 14A 2100413
2 GRAPHIC img215256168_0.jpg GRAPHIC 17621
3 GRAPHIC img215256168_1.jpg GRAPHIC 17621
4 GRAPHIC img215256168_2.jpg GRAPHIC 51719
5 GRAPHIC img215256168_3.jpg GRAPHIC 43801
6 GRAPHIC img215256168_4.jpg GRAPHIC 650877
7 GRAPHIC img215256168_5.jpg GRAPHIC 475404
  Complete submission text file 0000950170-23-008651.txt   6198476

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evok-20230317_pre.xml EX-101.PRE 6745
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evok-20230317_def.xml EX-101.DEF 5239
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evok-20230317.xsd EX-101.SCH 5061
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evok-20230317_lab.xml EX-101.LAB 10707
14 EXTRACTED XBRL INSTANCE DOCUMENT evok-20230317_htm.xml XML 241488
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36075 | Film No.: 23743063
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences